Michael Makris: How Haemophilia Care Is Delivered in China
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at University of Sheffield, reposted from RPTH Journal on LinkedIn:
”If you would like to know how haemophilia care is delivered in China then have a look at this paper.”
Quoting RPTH Journal‘s post about a recent article by Yun Wang et al, adding:
”Inherited bleeding disorders in China: a rapidly evolving therapeutic and healthcare landscape
With over 1.4 billion people, China faces a growing demand for the diagnosis and treatment of inherited bleeding disorders (IBDs), particularly haemophilia.
A new review in RPTH Journal takes stock of the remarkable progress made in recent years and the road ahead.
Key highlights:
- China is rapidly expanding its domestic manufacturing capacity for IBD therapeutics, from basic replacement therapies to advanced treatments including gene therapy
- A tiered healthcare system for haemophilia is being developed to optimise resource allocation and standardise care across both rural and urban areas
- A diverse pipeline of investigational domestic novel drugs is under active development
- The goal: more efficient, cost-effective, and accessible care for patients nationwide
This review offers a comprehensive overview of where China stands today, and where it is headed, in the management of inherited bleeding disorders.
The combination of domestic drug innovation and an evolving healthcare delivery system could significantly improve outcomes and quality of life for patients across the country.”
Title: The therapeutic landscape of inherited bleeding disorders in China
Authors: Yun Wang, Feng Xue, Man-Chiu Poon, Renchi Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Ferritin Levels and Transferrin Saturation, Reflecting Rapid Iron Accumulation and Reduced Iron Utilization
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination
-
Jun 3, 2026, 16:04Gurpreet Kaur Sagoo: Diagnosing PNH in Aplastic Anaemia – Looking Beyond the Marrow
-
Jun 3, 2026, 16:04Jan Hartmann: An Illustrated Review Of Viscoelastic Testing Reaches 100 Citations
-
Jun 3, 2026, 16:01Andrea Losito: For Stroke Survivors, Having a Community that Understands and Triumphs Can Make a Lasting Impact
-
Jun 3, 2026, 15:54Karen Phillips: Surprisingly High Cumulative Clinical Bleeding Events In Post-Ablation AF Patients